pentobarbital will decrease the level or effect of ripretinib samhälle affecting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital will decrease the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with stark CYP3A4 inducers can result in decreased serum concentrati